Novo has led a $17m series E investment in iRhythm Technologies with existing backer Norwest Venture Partners.
US-based iRhythm Technologies, a healthcare information company which carries out long-term cardiac monitoring, received further backing in this round from Norwest Venture Partners, which led iRhythm’s $17m series E financing.
The new funding will be used to further accelerate market growth for iRhythm’s ZIO arrhythmia-detection service, to expand technology development and to continue to establish clinical evidence to support its flagship product.
Kevin King, chief executive officer of iRhythm, said: “We are pleased to have Novo A/S as a new…
